Calidi Biotherapeutics Inc. Gains 60.19%
Wed, Nov 13, 2024 at 07:26 PM
Calidi Biotherapeutics Inc. (CLDI:NYSEMKT) rocketted at $3.38, a gain of 60.2%. On Wed, Nov 13, 2024, CLDI:NYSEMKT hit a New 2-Week High of $3.38. The stock appeared on our News Catalysts scanner on Wed, Nov 13, 2024 at 05:02 PM in the 'PUBLIC OFFERING' category. From Thu, Oct 31, 2024, the stock recorded 77.78% Up Days and 80.00% Green Days
About Calidi Biotherapeutics Inc. (CLDI:NYSEMKT)
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.
Top 10 Gainers:
- Microvast Holdings Inc. (MVST:NASDAQ), 340.01%
- Pulmatrix, Inc. (PULM:NASDAQ), 72.82%
- BTC Digital Ltd. (BTCT:NASDAQ), 68.1%
- Nature's Miracle Holding Inc. (NMHI:NASDAQ), 65.69%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 61.24%
- Calidi Biotherapeutics Inc. (CLDI:NYSEMKT), 60.19%
- BBQ Holdings, Inc. (DAVE:NASDAQ), 44%
- Kaixin Auto Holdings (KXIN:NASDAQ), 43.15%
- Digital Brands Group Inc. (DBGI:NASDAQ), 40.59%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 37.79%